Mucus Relief
Product Images NDC 55910-732

1 FDA label image from Dolgencorp, Inc. (dollar General & Rexall) · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief (NDC 55910-732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dolgencorp, Inc. (dollar General & Rexall), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin 1200 mg (Mucus Relief 1200 mg Extended Release Caplets 1)

Guaifenesin 1200 mg (Mucus Relief 1200 mg Extended Release Caplets 1)
Mucus Relief Maximum Strength extended-release tablets by Dolgencorp, Inc. Each tablet contains 1200 mg of Guaifenesin as an expectorant. The label highlights 12-hour relief, indicating it helps relieve chest congestion and thins mucus. The package contains 14 tablets and compares to the active ingredient of Maximum Strength Mucinex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.